candoxatril has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carretero, OA; Liu, YH; Oja-Tebbe, N; Shesely, EG; Xu, J; Yang, F; Yang, XP | 1 |
| Casley, DJ; Johnston, CI; Yasujima, M; Yoshida, K | 1 |
2 other study(ies) available for candoxatril and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Collagen; Disease Models, Animal; Echocardiography; Heart; Heart Failure; Indans; Liver; Lung; Mice; Mice, Knockout; Muscle Cells; Neprilysin; Organ Size; Propionates; Pyridines; Ramipril; Thiazepines; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2004 |
Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiomegaly; Drug Evaluation, Preclinical; Hemodynamics; Indans; Kidney; Male; Myocardial Infarction; Myocardium; Neprilysin; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 1998 |